chrisvoncsefalvay/vaers-outcomes huggingface dataset:
metallic taste in mouth within 5  tingling in lips, face and mouth followed by tightening of the throat in 20 minutes. Symptoms subsided and return over a two hour time peroid. Treated with 50mg Benadryl. Felt general weakness, fatigue and mild tingling in face for three days
patient had never had the flu from a shot but patient have had reactions that left me feeling bad; Initial information was received on 05-Dec-2020 regarding an unsolicited valid non-serious case from a non-health care professional/consumer (patient's wife) via social media.  This case involves a male patient of unknown age who never had the flu from a shot but patient have had reactions that left me feeling bad (feeling abnormal), while patient was treated with influenza vaccine.  Medical history, medical treatment(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient never had the flu from a shot but patient have had reactions that left me feeling bad (feeling abnormal).  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
Patient inadvertently administered adult dose of Pfizer covid  vaccine  instead of Pfizer 5-11 covid vaccine. Patient had no adverse symptoms from vaccination.
Patient called on the phone and stated she had a reaction to the vaccine given on 11/20.  She said that it began the evening of 11/20 and into 11/21.  She said that it started with her arm and she got advice from a healthcare professional that told her to take Benadryl.   The adverse reaction got worse the next day 11/22 with patient stating it moved to her chest and prompted a ER visit (antibiotic prescribed) and she missed some days from work.
I had a reaction to dose 4 including lethargy and exhaustion that lasted for 30 days. It started within 8 hours of the 4th dose. COVID- 19 symptoms started on 06/26/22; tested positive on 06/28/22. On the evening of the 26th I felt exhausted and tired. On Monday, I had extreme sore throat, lethargy, and sore throat, but no fever. I took COVID-19 test and it was negative and that day I slept another 5 hours after sleeping all night. My throat continued to get worse, and the next day I woke up and took a test and it was positive. I had exhausted and flu-like symptoms, achiness, and then I had a hard time stringing words together. Wednesday I felt better and  throat wasn't sore but I did overdo myself that day. Thursday I was back in bed and Friday I was feeling better and taking care of myself and I noticed then that I'm really tired even though I'm sleeping and eating well and taking my supplements and antiviral and immune support medication to get past this. Today was my first negative test 07/05/22. I did do a telehealth visit. I also read pulse ox and the lowest was 93 the 2nd or 3rd day, and as of yesterday I was back to 97.
Headache, no appetite  and ibs acting up a LOT ! Every day several times a day.
Vaccination provided at approximately 9:20am.  9:30am: Patient stated he was beginning to feel itchy and some trouble breathing, but only requested Diphenhydramine. Diphenhydramine 50mg given IM.  Pulse was 76, respiration was 12.  Emergency services initiated. 9:40am: Pulse 78, respiration 13.  Ambulance arrived approximately 9:44am.  Paramedics did not note any signs of urticaria, patient stated he was breathing ok.    Patient was alert and responsive throughout.  Denied further evaluation or transport to hospital for further assessment by paramedics.  Requested patient have others also continue to keep an eye on him and seek emergency services if necessary.
Post vax, the vaccinee experienced joint pain. He initially treated himself with Advil. He then presented to his physician who treated him with anti-inflammatories.
After 2nd shot of Pfizer was given patient sat for 10 minutes before stating he was dizzy and felt like he was going to faint. At that point he was instructed to lay down and vital signs were monitored. An ambulance was called and EMT's took over monitoring. Patient subsequently recovered and hospitalization was not necessary
On 08/01/2016, employee reported she "had a not so good reaction to (the 1st in series of 2).  I had to call off work because of it.  Horrible body aches, fever, chills, and couldn't get out of bed for a day.  I read the reactions and it was all of those."
fainted; Hit his head on the floor; pale looking; This is a spontaneous report from a contactable pharmacist. A 12-year-old male patient received first dose of bnt162b2 intramuscularly administered in right arm on 08Jun2021 at 15:00 (Batch/Lot Number: EW0187) at age of 12-year-old as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Facility where the most recent COVID-19 vaccine was administered was pharmacy or drug store. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. On 08Jun2021 at 15: 10, 10 minutes after the shot (also reported on 08Jun2021 at 15: 00), the patient fainted, hit his head on the floor, conscious but pale looking. Patient's weight 160 lbs, vitals normal per grand ma and emt left after having him seat on the chair. The adverse event result in Emergency room/department or urgent care. The outcome of events was recovered on Jun2021.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on chronological connection to the vaccine a causal relationship between reported event syncope and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
localized reaction; Initial information received on 22-Nov-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves Elderly patient who experienced localized reaction, while he/she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past vaccination(s) included Shingrix with local reaction (6 months earlier) and TAP with no adverse event (about a month ago).  The patient's past medical history, medical treatment(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, The patient developed a non-serious localized reaction (local reaction) (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was localized reaction.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for localized reaction.  batch number has been requested.
had covid infection and then again for 10 days around each pfizer covid vaccine shot; had covid infection and then again for 10 days around each pfizer covid vaccine shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "colonoscopy", start date: 2015 (unspecified if ongoing), notes: Reports a normal colonoscopy in 2015 with no polyps. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2020, outcome "unknown" and all described as "had covid infection and then again for 10 days around each pfizer covid vaccine shot". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Dec2020) she had covid infection, notes: States she stopped it (xeljanz) for 3 weeks in Dec2020 when she had covid infection and then again for 10 days around each pfizer covid vaccine shot (as per recommended by her hcp).  Clinical course: The patient stopped Xeljanz for 3 weeks in Dec2020 when she had Covid infection and then again for 10 days around each pfizer covid vaccine shot (as per recommended by her HCP). Her HCP was referring her to a GI specialist.  The lot number for bnt162b2 was not provided and will be requested during follow up.
a PEDIATRIC dose was given to a 27 year old; a PEDIATRIC dose was given to a 27 year old; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 27-year-old female patient who received HBV (Engerix B pediatric) (batch number K32, expiry date 24th April 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd March 2022, the patient received the 3rd dose of Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 2nd March 2022, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The health care professional reported that a pediatric dose was given to a 27 year old patient which led to underdose and adult use of a child product. No reaction was reported.  The reporter consented to follow up via email.
Dry cough, blood clot in left thigh and right calf, blood clot burst causing pulmonary embolism; was put on blood thinners.
When vaccine was administered, I felt a sharp pain down to my elbow immediately, could hardly move arm x 2 days. Got better, but pain is present. Still after 15 days when pulling, pushing, or lifting objects. Throbs at night while sleeping.
Following 1st dose: First VERY itchy arms, turn back, then chest. Skin was red & very sensitive  like a sunburn.  Sore arm. Following 2nd dose: metallic taste/smell immediately and for 12 hours, aches, a headache, fatigue and sore arm.
Dose two was on 05/15/2021 also at a covid vaccination site lot 026C21A My daughter has not had a period since right before her first vaccination on 17 Apr (second dose 15 May) and it is currently 2 June and she is NOT pregnant.  I am trying to find a GYN appt for here assap
On 3/18/22 developed symptoms of extreme headache, pain across (L) side of forehead.  Developement of small vesicles and itching. Eye swelling (L) Diagnosed with Shingles
Inability to move/raise arm. Numbness in injected arm. Stiffness in neck and shoulder.
Patient received vaccine first before child. 5 mins after being administered the vaccine, mother verbally announced she was feeling slight dizzy. I had mother sit down on a chair slowly, I had applied a cold pack behind her neck. Mother had said she felt like she's about to fait, so I quickly but slowly had her get on the exam table to lay her down. After 2 mins a had taken her blood pressure, 106/71 pulse: 68- pt stated her reg BP was around 110/70. I had given her a juice for her to drink. She stated she only had coffee this morning a  bite of a cake. Mom was verbal the whole time with out fainting. Stayed in the office for about 25-30 mins to make sure she was still feeling good. Before leaving the office I retook her blood pressure, 101/67 Pulse 63, then I gave her a sucker for her to have. 5 mins later she felt way better and stated she was good to leave the office.
I have intense insomnia and internal tremors that are consistent and will not stop at all they start when I try to fall asleep, as soon as I lay down my tremors start it is all internally but prevents me from sleeping, in order to sleep I have been prescribed high dose benzos or colonzapam in order to get sleep
Pt found vomiting in observation area, RN present.  Noted 5-10mL clear content emesis.  Pt denied experiencing any other abnormal sx.  Per pt, reported drinking 3-4 alcoholic drinks plus 3-4 tequila shots last night.  He is likely having emesis related to alcohol consumption.  Monitored for a total of 45mins.  BP 141/82, HR 98, RR 16, T 96.8.  Patient stable and released from the vaccination site.
Patient called on Wed 11/11/15 w/complaint of a red, angry rash w/a blister on arm where ZOSTAVAX shot was given.
On 11/18/2000 the child presented with 19-20 chicken pox lesions. Unspecified medical attention was sought. The nurse reported that the patient recovered from the chicken pox. No further information is available.
Pt has gastroenteritis over the past several days; apparently started w/vomiting & then diarrhea; morning of adm had some 7-UP & started having some jerking of legs; appeared to be a sz by hx;
Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe
Within an hour of receiving my shot I started to develop a sore throat that continued to get worse throughout the day. Next day still sore throat and added congestion, coughing, mild chest pain, and dizziness. It is now the 5th day since I got the shot and my symptoms are still here.
Dizziness, lightheaded and brain fog started 7/11 around afternoon time and has lasted till today 7/16, been feeling very fatigued as well.
This is a spontaneous report from a contactable consumer or other non-healthcare professional (husband) reporting for a patient (his wife). A 28-year-old female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection; batch/lot# not reported), at the age of 28, via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunization. Medical history included cyst from an unknown date and unknown if ongoing. Patient had previously gone to the skin clinic and was taking a prescribed medication for a cyst. She was informed by pharmacist at clinic this would not cause any interactions with the Pfizer COVID-19 vaccine. The patient's concomitant medications not reported. On an unspecified date, after patient received the Pfizer COVID-19 vaccine (2 or 3 days later), patient experienced with swollen glands on both sides of her throat. Her throat felt swollen on the inside and she was losing her voice. Her symptoms seemed better yesterday but they are bad again today. It was confirmed by patient no difficulty breathing due to swelling in the throat. No assessment provided. Husband wanted to know if these side effects are normal or commonly reported. He hoped this medicine did not cause an interaction. The outcome of the events was unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
Information has been received from a nurse referring to an unspecified number of patients of unknown gender and age. The patients' pertinent medical history and drug reactions/allergies were not provided. On unspecified dates the patients were vaccinated with M-M-R II (dose, route and lot # were not provided). On multiple unspecified dates the patients experienced redness and swelling at injection site for 3-5 days following the administration of M-M-R II, but no induration had developed. The nurse did not have any further details on any of the patients who experienced only redness or swelling at the injection site. The outcome of the events was considered as recovered/resolved. The causality of the events was not provided. This is one of two reports received from the same source. Additional information has been requested.
1st dose pain in injection site lasting 2-3 days 2nd dose pain in injection site lasting 2-3 days, fatigue and muscle stiffness lasting 2 days
A non-serious spontaneous report of cold-like symptoms with manifestation of congestion, headaches, fatigue and muscle pain has been received from a consumer concerning an adult female, subsequent to receiving FLUMIST. Neither the patient's past medical history nor the concomitant medications were reported. The patient received FLUMIST on an unknown date. The patient reported experiencing cold-like symptoms (congestion, headaches, fatigue, and muscle pain), coming on quite suddenly the day after taking FLUMIST. The outcome of was unknown.
01/10/22 presents to EC ED for "fever" "short of breath" PMHx of "DVT/PE, CAD, ischemic cardiomyopathy, PAF on Xarelto, HTN, HLD"
79-yo female was given Tdap vaccine 0.5ml IM and pneumococcal conjugate 13 vaccine (PREVNAR 13) 0.5ml IM in the left deltoid at 1522 on 6/23/17 in clinic. Patient reported that burning and redness started around the time the vaccine was given. Patient and son called clinic on 6/29 to report that her arm was red, swollen with discomfort.  Patient was asked to come to clinic and patient came to clinic on 6/30/17. MD assessed patient and noted mild redness and swelling to upper left arm where vaccines were given. There was mild streaking and discomfort. Patient denies fevers but redness increased over last 24 hours. MD recommended ice and cool compresses, prescribed doxycycline 100mg PO twice daily x 7 days and to take acetaminophen and diphenhydramine as needed. MD could not rule out cellulitis. Patient was advised to return to MD if the symptoms do not completely resolve in 7 days.
Presented to hospital with fever, cough, SOB, chest tightness, loss of taste/smell.
Mother telephoned 05/22/2003 with concerns of mental status changes and new onset migrating urticaria-treated with antihistamines.  Allergist is presently involved possible correlation suggested.
Information has been received from an unspecified reporter referring to an 8 week old patient of unknown gender. The patient's concomitant medication, concurrent conditions and medical history were not reported. On 23-SEP-2016 the patient was vaccinated with PEDVAXHIB (lot #, expiration date, dose and route were not reported) for prophylaxis. The vaccine was administered at a Heath Center during the temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA003650.
Sharp nerve pain throughout body (including fingers, toes and ears), particularly near joints. Began roughly 6 hours after vaccination and has continued. OTC pain meds do not control or stop the pain. I had the same reaction for my second Covid Moderna vaccine.
Flu shot given on 11-15-12 at 9 am. Noted edema, erythema and induration few h after at arm. 4+ h after still redness and swelling but better.
pt recv vax 17OCT95 & later that afternoon arm became sore;that noc it became painful w/use;the pain was treated w/APAP & ice;
FAST SPREADING RASH AFTER 2ND VACCINE ON TRUNK, NECK,ARMS,FACE GIVEN BENADRYL, PEPCID, EPIPEN Narrative:
Hardening, pain, redness & swelling at site of injection (Left deltoid)@ 12:30-9/15/20 - Ice, Tylenol, Claritin & Arnica, topically Fatigue 9/16/20 Redness extending to inner aspect of Left upper arm. 9/17/20 continues claritin
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 08-JUN-2016, the patient was vaccinated with a dose of improperly stored ZOSTAVAX 19400 plaque forming units (PFU) (lot # L036823 with expiration date 24-DEC-2016, dose and route were not reported). The vaccine was improperly stored at 12 degree Fahrenheit for 4 months. There was no previous temperature excursion and no data logger was involved. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Fever up to 101.2.  Headaches.  Body Aches.  Increased resting heart rate.  Shortness of breath on any exertion (i.e. walk 20'..)  Increased heart rate to 110's with minimal exertion
Coughing up so much stuff; chest froze; shoulders froze; breathing difficult; couldn't cough up stuff / asthmatic coughing; This case was reported by a consumer via call center representative and described the occurrence of chest tightness in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included lung disorder. Concomitant products included medication unknown, medication unknown (Nebulizer (Name Unknown)).   On 23rd May 2019, the patient received the 1st dose of Shingrix (intramuscular). On 23rd May 2019, 10 min after receiving Shingrix, the patient experienced chest tightness, frozen shoulder, difficulty breathing and cough resembling asthma. On 29th July 2019, the patient experienced productive cough. On 29th July 2019, the outcome of the chest tightness and cough resembling asthma were recovered/resolved. On an unknown date, the outcome of the frozen shoulder was recovered/resolved and the outcome of the difficulty breathing and productive cough were unknown.   It was unknown if the reporter considered the chest tightness, frozen shoulder, difficulty breathing, cough resembling asthma and productive cough to be related to Shingrix.  Additional information received were as follows: Within 10 minutes of receiving the dose, the patient's chest and both shoulders froze. The patient could not breathe well and she could not cough up stuff in her lungs, which she needed to do due to her lung problem. While the patient had some asthmatic coughing, she has not been able to cough up the stuff in her lungs. 67 days after receiving Shingrix, the patient started coughing up so much stuff. The reporter consented to follow up. The case was related to patient.
5/17/10 Patient return for TB reading. Parent said patient had papullar eruption from faces and abdomen.
two and a half days after receiving the shot I came down with a fever, chills, body aches and pain, tiredness, nerve shocks and a shingles like rash and pain on my left leg.  Called a COVID nurse who took down my symptoms; conferred with a doctor .  Was told to keep track of my fever; take Tylenol and if symptoms got worse to call 911.
During the covid clinic by pharmacy the pharmacist was told by the staff members that the patient was receiving his second dose of covid vaccine.  Upon returning to the pharmacy they learned that it was his third dose.  (1/14 ; 2/4 ; 2/25 )